190 related articles for article (PubMed ID: 26356696)
1. Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis.
Zhang Y; Wang J; Sui X; Li Y; Lu K; Fang X; Jiang Y; Wang X
Medicine (Baltimore); 2015 Sep; 94(36):e1432. PubMed ID: 26356696
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL).
Markovic O; Marisavljevic D; Cemerikic-Martinovic V; Martinovic T; Filipovic B; Stanisavljevic D; Zivković R; Hajder J; Stanisavljevic N; Mihaljevic B
Med Oncol; 2012 Dec; 29(5):3515-21. PubMed ID: 22528517
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
[TBL] [Abstract][Full Text] [Related]
5. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida C; Haioun C; Gaulard P; Lepage E; Morel P; Briere J; Dombret H; Reyes F; Diebold J; Gisselbrecht C; Salles G; Altieri DC; Molina TJ
Blood; 2000 Sep; 96(5):1921-5. PubMed ID: 10961895
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of survivin and caspase-3 expression in diffuse large B-cell lymphoma].
Xiang XJ; He YJ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):298-301. PubMed ID: 16875633
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
9. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
11. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
12. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.
Krieg A; Werner TA; Verde PE; Stoecklein NH; Knoefel WT
PLoS One; 2013; 8(6):e65338. PubMed ID: 23755220
[TBL] [Abstract][Full Text] [Related]
14. C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studies.
Zhou K; Xu D; Cao Y; Wang J; Yang Y; Huang M
PLoS One; 2014; 9(4):e95020. PubMed ID: 24740248
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
Schlette EJ; Medeiros LJ; Goy A; Lai R; Rassidakis GZ
J Clin Oncol; 2004 May; 22(9):1682-8. PubMed ID: 15117990
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
18. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
20. [Progress of study on survivin in diffuse large B-cell lymphoma--review].
Dou HJ; Hu JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1487-90. PubMed ID: 19099670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
